2397 Stock Overview
Develops DNA microarrays in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
DNA Chip Research Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥701.00 |
| 52 Week High | JP¥2,100.00 |
| 52 Week Low | JP¥610.00 |
| Beta | 0 |
| 11 Month Change | -1.41% |
| 3 Month Change | -12.27% |
| 1 Year Change | -3.44% |
| 33 Year Change | 43.65% |
| 5 Year Change | -2.50% |
| Change since IPO | -89.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2397 | JP Life Sciences | JP Market | |
|---|---|---|---|
| 7D | -1.5% | 5.2% | -0.5% |
| 1Y | -3.4% | -20.1% | 10.8% |
Return vs Industry: 2397 exceeded the JP Life Sciences industry which returned -20.1% over the past year.
Return vs Market: 2397 underperformed the JP Market which returned 10.8% over the past year.
Price Volatility
| 2397 volatility | |
|---|---|
| 2397 Average Weekly Movement | 5.1% |
| Life Sciences Industry Average Movement | 5.7% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2397 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2397's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 37 | Ryo Matoba | www.dna-chip.co.jp |
DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities.
DNA Chip Research Inc. Fundamentals Summary
| 2397 fundamental statistics | |
|---|---|
| Market cap | JP¥4.74b |
| Earnings (TTM) | -JP¥118.00m |
| Revenue (TTM) | JP¥766.00m |
6.2x
P/S Ratio-40.2x
P/E RatioIs 2397 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2397 income statement (TTM) | |
|---|---|
| Revenue | JP¥766.00m |
| Cost of Revenue | JP¥472.00m |
| Gross Profit | JP¥294.00m |
| Other Expenses | JP¥412.00m |
| Earnings | -JP¥118.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -17.44 |
| Gross Margin | 38.38% |
| Net Profit Margin | -15.40% |
| Debt/Equity Ratio | 0% |
How did 2397 perform over the long term?
See historical performance and comparison